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Introduction
Gastric cancer is one of the most common tumors 
of the gastrointestinal tract, it has high morbidity and 
mortality rates, and it is more than Northeast Asia, 
including China, Japan and South Korea (Kanda et al., 
2016). The pathogenesis of gastric cancer is unclear; 
however, social-economic environment, lifestyle, 
nutrition, education, smoking and Helicobacter pylori 
infection are all associated with its occurrence (Park et 
al., 2015). 
Gastric cancer is a multifactorial disease that various 
factors such as infectious agents involved in its creation, 
Infectious agents such as H.pylori and EBV are accepted as 
causative microorganisms for GC (Camargo et al., 2015). 
In addition the study, which is done in 2014, confirmed the 
role of latent cytomegalovirus infection in GC (Chen et 
al., 2015). Human cytomegalovirus (HCMV) is a β-herpes 
virus that may cause the infection of multiple cell types in 
human. The virus persists in 30–100% of the population 
worldwide, particularly in certain areas of Africa and Asia 
(Reza et al., 2015). Asymptomatic infection, caused by 
latent state HCMV in healthy individuals, may increase the 
risk of atherosclerosis and age-related immune senescence 
1Department of Medical Microbiology, 2Pathology and Stem Cell Research center, 3Leishmania Research Center, Kerman University 
of Medical Sciences, Kerman, Iran  *For correspondence: hamid2008kmu@gmail.com 
Abstract
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(Grim et al., 2010; Mott et al., 2013). Furthermore, severe 
or acute disease may be induced in immunocompromised 
cases, including acquired immunodeficiency syndrome 
patients and transplant recipients, due to the reactivation 
of latent HCMV (He et al., 2011; Falasca et al., 2014). 
An increased number of cases of gastrointestinal diseases 
caused by HCMV infection have been reported, including 
ulcerative colitis and esophageal ulcers (Jang et al., 2009). 
In addition, emerging evidence has indicated that HCMV 
infection may be associated with human malignancies, 
including colon and prostate cancer (Chow et al., 1997; 
Lu et al., 2010).  However, the association between gastric 
cancer and HCMV remains unclear. 
Epstein-Barr virus (EBV) is a human herpes virus with 
oncogenic activity. The EBV genome can be detected in 
malignancies of both lymphoid and epithelial cell origin, 
such as Burkitt’s lymphoma (BL) and nasopharyngeal 
carcinoma (NPC) (Matsuura et al., 2010). In 1990, EBV 
genomes were detected in gastric carcinomas using 
polymerase chain reaction and in situ hybridization (ISH) 
for EBV-encoded small ribonucleic acid 1 (EBER1) 
(Saridakis et al., 2005). These findings indicated that 
EBV-associated gastric carcinomas comprise about 
10% of all gastric carcinomas worldwide. Since EBV 
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infection may be involved in the early stages of gastric 
carcinogenesis (Sairenji et al., 2001). EBV spreads by 
the oral route, after primary infection, EBV establishes 
the lifelong virus carrier state, called latent infection, 
which expresses a limited set of viral genes required for 
viral episome maintenance, thereby conferring a survival 
advantage to the infected cell (Ryan et al., 2010; Reza et 
al., 2015). The presence of EBV DNA was linked with 
severe forms of Gastric cancer. Epstein-Barr virus encoded 
small RNA (EBER) is non-polyadenylated, noncoding 
RNA that exists abundantly in EBV-infected cells (Ngan 
et al., 2001). EBER induces signaling from the Toll-like 
receptor 3 (TLR3), which is a sensor of viral double-
stranded RNA (dsRNA) and induces type I IFN and pro-
inflammatory cytokines and the majority of the released 
EBER existed as a complex with a cellular EBER-binding 
protein (Cainap et al., 2015).  
The most frequently mutated gene in Gastric cancer 
is the p53 tumor suppressor gene. When the p53 gene is 
mutated, the cell cycle controlling is lost and this fact 
is leading to the development of neoplasms (Bargiela-
Iparraguirre et al., 2016). The present study was carried out 
in an attempt to determine whether there is a relationship 
between mentioned viral infection and p53 expression in 
Gastric cancer. EBV and CMV belong to the herpesvirals 
that have linear dsDNA. Gastric cancer is the fourth 
common cancer in men and the fifth in women and in 
terms of mortality from cancer is in rank second (Babaei 
et al., 2010). About 10 percent of all deaths from cancer 
have been attributed with GC; and around 70 percent of 
total stomach cancers have been reported from developing 
countries (Camargo et al., 2015). Mortality from this 
cancer in developing countries is 10 percent more than in 
developed countries. In Iran, this cancer is too important, 
and unlike developed countries its incidence is increasing 
(Camargo et al., 2014).
This study was carried out evaluation frequency of 
EBV and CMV in patients with Gastric cancer. We for the 
first time examined the frequency of CMV in patients with 
gastric cancer. Molecular techniques are the most reliable 
assays in viral presence detection in comparison to other 
tests based on host antibody. Real-Time PCR is the most 
sensitive methods and have been used frequently to detect 
viruses.  In this study, the presence of EBV, and CMV in 
GC tissue samples were studied from paraffin-embedded 
malignant tissues in Iranian patients with gastric cancer 
by a standard Real Time PCR assay for finding the 
relationship between those viruses and gastric cancer.
Materials and Methods
Patients 
Paraffin embedded blocks samples from patients with 
Gastric Cancer, referred to the department of Pathology, 
Afzalipour Pathobiology Lab, Kerman province, Iran, 
during April 2009 -March 2014 were identified. 90 
formalin-fixed paraffin-embedded tumor tissues of 
patients collected. Types of samples for gastric cancers 
were Adenocarcinoma (diffuse type and Intestinal type) 
that in the diffuse type mucinous and in intestinal type 
signet ring cell were shown. The most type of caricinoma 
was Intestinal Adenocarcinoma. The present study is 
based on a retrospective examination of Gastric Cancer 
diagnostic biopsy or surgery samples from clinical 
cases, all original hematoxylin and eosin (H&E) slides 
and Immunohistological stain recut from tissue blocks 
were reviewed. In total, samples were screened for EBV 
DNA, CMV DNA , mRNA expression level of EBER, 
expression level of PP65 antigen and level of expressed 
p53. This project was approved by the research center 
ethics committee of the Kerman University of Medical 
Sciences.
Deparaffination samples 
Paraffinated blocks from the 90 tumor samples were 
cut in 3-μm sections and 5 sections, patients were collected 
in the same micro-centrifuge tube. Samples were de-
waxed in 800 μl xylene, All micro-centrifuge tube located 
for 10 min in a 60 °C heated block and centrifuged at 
10,000 rpm for 1 minute , supernatant was removed. This 
step was then repeated three times. Add 500 μl absolute 
ethanol, centrifuge at 10,000 rpm for 1 minute, the samples 
were then dried in a 70°C heated block with open lids for 
5-10 min for remove residual ethanol.
Tissue digestion 
According to samples (biopsy or Paraffinated blocks), 
200-400 μl of Tissue Lysis Buffer was added to each tube 
[4 M Urea, 200 mMTris, 20 mMNaCl, 200 mM EDTA; 
PH=7.4 (25°C)]. To all tubes added 20-40 μl proteinase 
K, Samples were gently vortexes and located for 10 min 
in a 60°C heated block, and all samples were subsequently 
incubated at 37°C overnight. 
DNA and RNA Extraction
The next day, 200 μl of Binding Buffer [6 M 
Guanidine- Hcl, 10mM Urea, 10mM Tris-Hcl, 20% 
Tritonx-100 (v/v); PH=4.4 (25°C)] was added to each tube 
with gently vortex. DNA was isolated using a QIAamp 
DNA Mini kit (Qiagen, Germany) and Total RNA was 
extracted using RNAeasy mini kit (Qiagen, Germany) 
according to the manufacturer’s instructions. Extracted 
DNA and RNA pellets were resuspended in 70μl of pre-
warmed Elution buffer and stored at -70°C until use.
Virus Detection using Real time PCR 
Real time PCR was carried out using EBV, and CMV 
Real Time PCR kit (Inter Lab Servise, Russia) following 
instruction manual.
Real Time PCR
For determination expression level of EBER, p53 
and PP65 antigen mRNA, reverse transcription real time 
PCR (rReal Time PCR ) was carried out by using the first 
strand cDNA synthesis kit by RevertAid cDNA synthesis 
kit (Thermoscientific,USA). Briefly, RNA samples were 
heated to 65°C for 10 minutes and then chilled on ice. The 
uniform suspension of bulk first-strand cDNA reaction 
mix was added according to the manufacturer’s protocol. 
One μl of DTT solution, and 1 μl of random hexamer 
(N)6 primer (0.2 μg) were then added to the heat-denatured 
RNA. Samples were mixed properly by pipetting up 
and down several times and then incubated for 1 hour at 
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42°C. For Real time PCR, the Quanti Tect Probe PCR 
Kit (Qiagen, Germany) used base on instruction kit. Real 
time PCR primers and probes were design for EBER, p53 
and PP65 antigen mRNA after alignment of these regions 
between all of them in EBML-EBI and as an internal 
control, β-Actin were purchased from Metabion company 
(Germany) (Table1). 
Statistical analysis 
Chi-square test or Fisher’s exact test was conducted 
using SPSS version 17 for the association between the 
presence of DNA viruses genome and other characterizes 
(values P=0.05 were considered statistically significant).
Results 
Ninety- patients with Gastric Cancer (GC) were 
selected during April 2009 -March 2014. Paraffinated 
blocks or biopsy samples from these patients were 
selected for evaluation frequency of HCMV, EBV virus 
and evaluation level gene expression of P53, EBER and 
PP65 using Real Time PCR. From total 90 samples, 17 
(18.8%) samples were female and 73 (81.1%) were male. 
Mean ±SD of age were 60.46±14.88 years old,. Minimum 
and maximum age for male were 20 and 75 years old and 
for female were 34 and 86 years old. Of ninety specimens, 
EBV and CMV were detected in 10 cases (11.1%) and 
in seven cases (7.77%), respectively. One out of 17 
female patients (5.88%) and nine out of 73 male patients 
(12.32%) were positive for EBV, one out of 17 female 
patients (5.88%) and six out of 73 male patients (8.22%) 
were positive for CMV. The mean age for EBV-positive 
patients was 60.46±14.88 years and the mean age for 
CMV- positive patients was 67.85±12.25 years (Table 2, 
3). Result of PCR in different type of adenocarcinoma 
was shown in Table 4. Frequency different types of 
carcinoma were shown in figure 1, Types of samples for 
gastric cancers were Adenocarcinoma (diffuse type and 
Intestinal type) that in the diffuse type, mucinous and in 
intestinal type, signet ring cell were shown. The most type 
of carcinomas was Intestinal Adenocarcinoma. To catch 
more information for the role of P53 protein in making 
tumors, all samples of this study used for P53 detection. 
Sidelines of benign tumors were collected. Different rate 
of P53 expression is shown in figure 2 and it is clear that 
in other groups uninfected for CMV, the expression of p53 
is normal and natural but when the PCR test of HCMV 
or EBV are positive, the rate of P53 dramatically drops 
which suggests that the reduction in amount of p53 may 
involve in making tumors. As it can be seen the expression 
levels of p53 in positive EBV, CMV cases are substantially 
reduced comparing with negative samples. Probably, other 
materials that are produced and released in virus life cycle 
may lead to reduced p53 in these cases.
To find if PP65 is important for GC tumor and the 
question of its effect on tumor production leaded us to 
study PP65 in our samples. In figure 3, PP65 mRNA 
expression in the different groups studied and seen the 
Figure 1. Frequency Types of Gastric Cancer Samples
Figure 2. Relative Expression of P53 in Different 
Samples
Table 1. Sequences of Primers and Probes for Real Time PCR in this Study
Name Forward Reverse Probe Location 
P53 CAGCATCTTATCCGAGTG GATGGTGGTACAGTCAGA CCAACCTCAGGCGGCTCATA 147-269
PP65 GCAGAACCAGTGGAAAGA GCAGAACCAGTGGAAAGA CGTACTGGTCACCTATCACCTGC 303-483
antigen 
EBER TGAGGAGATGTAGACTTGTA CTGGTACTTGACCGAAGA AACCTCAGGACCTACGCTGC 138-321
Figure 4. Relative Expression of EBER in Different 
Samples
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expression rate of PP65 antigen in the positive CMV 
patients is in the highest level (red column) but as it is 
shown in one negative CMV DNA sample some levels 
of expression were observed. In figure 4, EBER mRNA 
expression in the different groups studied and seen the 
expression rate of EBER RNA in the positive EBV 
patients is in the highest level (red column) but as it is 
shown in one negative CMV DNA sample some levels of 
expression were observed. Statistical analysis of results 
showed that there is a significant correlation between p53 
and tumor genesis. Our data defined that there is significant 
relationship between EBER expression and presence of 
EBV virus. In our study, a relation between the expression 
levels of pp65 and CMV infection was found in GC tumors 
production and it cannot be said that CMV, EBV virus is 
involved in GC tumors genesis.
Discussion
Gastric cancer is the fourth common cancer, and in 
terms of mortality from cancer is in rank second (Brenner 
et al., 2009). Every year about 1 million new cases of 
stomach cancer diagnosed and mortality from this cancer 
is some 700,000 cases (Parkin et al., 2005).
According to the results of the study, the frequency 
of EBV in patients with gastric cancer in Kerman is 11.1 
percent. The results of this study compared with previous 
studies in Iran (Tehran) that show a higher incidence 
of EBV-associated Gastric carcinomas (Abdirad et al., 
2007; Faghihloo et al., 2014a). Since prevalence of 
EBV-associated Gastric cancer is lower in areas with 
high incidence of Gastric cancer and in areas with low 
prevalence of Gastric cancer is more and because Kerman 
is region with low incidence of Gastric cancer (Sadjadi 
et al., 2007). The results of our study are justifiable. So 
cannot be said that the prevalence of EBV-associated 
gastric cancer is low in Iran because EBV-associated 
gastric cancer have different prevalence in different 
geographical areas, as in this study, unlike previous 
studies, the prevalence was higher. Like most studies, 
not did statistical analysis show a significant association 
show between age and EBV- associated gastric cancer. 
However a number of studies were shown tendency to 
involvement at at lower age (Kazakhstan and Colombia) 
(Carrascal et al., 2003; Alipov et al., 2005) or higher age 
(Mexico) (Herrera et al., 1999).
In most studies, sex differences favor of men, but 
not were some studies shown a significant relationship 
between sex and EBV-associated Gastric cancer. In this 
study, The EBV-associated Gastric cancer was seen more 
in men, but according to the statistical analysis of the 
results, not was a significant relationship found between 
sex and EBV-associated Gastric cancer (Camargo et al., 
2014). However, the absence of significant correlation can 
be attributed to the low number of positive samples and 
the limitation of statistical tests in the difference diagnosis 
in the low volume. In the present study of 90 cases with 
gastric cancer, CMV genome in 7 cases (1 female and 6 
male) was diagnosed. The frequency of CMV in patients 
with Gastric cancer in Kerman is 7.1%. In this study show 
a significant correlation between age and CMV- associated 
Gastric cancer. In our study according to the statistical 
analysis of the results, not was a significant relationship 
found between sex and CMV-associated Gastric cancer. 
However, the prevalence was in men higher than women. 
Since no study has been done in this area, there is no 
possibility of further examination of results. In a study 
in Iran , of ninety specimens, EBV was detected in six 
cases (6.66%). The mean age for patients EBV-positive 
gastric carcinomas was 72.1 years, whereas the mean 
age for the entire group was 65.7 years. Four out of 64 
(6.25%) male patients and 2 out of 26 (7.69%) female 
cases were positive for EBV. The present study shows 
that the frequency of EBV-associated gastric carcinoma 
in Iran is low. Differences of EBV-associated gastric 
carcinoma incidence in different countries may reflect 
the epidemiologic factors and dietary habits. Further 
analysis of clinical pathology features of EBV-associated 
Figure 3. Realtive expression of PP65 in Different 
Samples
Table 2. The Distribution of Carcinomas According 
to age, sex in EBV-negative and EBV-Positive Gastric 
Cancer
EBV-negative EBV-positive P-value
Age 62.03±12.48 60.45±14.88 0.701
Sex, N (%)
   Men 16 (20) 1 (10) 0.446   Women 64 (80) 9 (90)
Table 4. Frequency type of carcinoma and PCR result 
Type of 
Adenocarcinoma Num (%)
CMV 
Positive
EBV 
Positive 
Intestinal 60(66.6) 6 6
Mucinous 3(3.33) 1* 1*
Diffuse type 20(22.2) 0 1
Signet ring cell 7(7.7) 0 2
*In a sample of mucinous type both CMV and EBV were Positive
Table 3. The Distribution of Carcinomas According to 
age, sex in CMV-negative and CMV-Positive Gastric 
Cancer
CMV-negative CMV-positive P-value
Age 61.33±12.69 67.85±12.25 0.194
Sex, N (%)
    Men 16 (19.3) 1 (14.3) 0.746    Women 67 (80.7) 6 (85.7)
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gastric carcinoma using a larger number of cases would 
give invaluable insights into its etiology (Faghihloo et 
al., 2014b).  In a study for Identifying high-risk clusters 
of gastric cancer incidence in Iran, Gastric cancer was 
considered as the second most prevalent cancer in Iran. 
The most likely clusters were found in Ardabil, Gilan, 
Zanjan, East-Azerbaijan, Qazvin, West-Azerbaijan, 
Kurdistan, Hamadan, Tehran and Mazandaran between 
2007 and 2009. It was statistically significant at the 
p-value below 0.05. High risk regions included Northern, 
West-North and central provinces, particularly Ardabil, 
Kurdistan, Mazandaran and Gilan. More screening 
tests are suggested to be conducted in high risk regions 
along with more frequent epidemiological studies to 
enact gastric cancer prevention programs. (Kavousi et 
al., 2014).We found negative evidence of an association 
between HCMV or EBV virus infection and GC in this 
study. In addition, we showed dramatic differences in the 
expression of PP65 and EBER mRNA in these tumors 
which are irrelevant with tumor production. Based on 
our data, P53 expression is directly linked with CMV and 
EBV infection and in our positive CMV, EBV samples 
the rate of P53 dropped and helps to make tumors. In 
our study, 10 samples out of 90 were positive for EBV 
virus and EBER mRNA in EBV positive samples and 
only one sample negative for EBV, were detected. In our 
survey, P53 was detected in both positive CMV and EBV 
patients and decreased comparing to negative patients and 
beside the presence of PP65 in positive CMV, we could 
report some expression in negative CMV samples. In our 
study, we found the relation between age and sex in GC 
patients. We have got more positive GC in elderly cases 
and also reported that the presence and possibility of GC 
in men is higher than women. Although researches have 
a strict causal relationship between HCMV and EBV 
infection and GC tumors, but future studies need to focus 
on determining the role of HCMV and EBV as a gastric-
initiating event. Moreover, finding different proteins with 
varied functions and different types of CMV and EBV can 
be proposed (Corvalan et al., 2005; Fyock et al., 2014; 
Babacan et al., 2016). 
In conclusions, This study shows that the frequency 
of EBV-associated Gastric cancer is high in Kerman. 
Our stady is the first study about the frequency of CMV 
in patients with Gastric cancer. According to the results 
of this study and other studies, were conducted about the 
relationship between CMV and other human cancers, 
CMV can be associated with Gastric cancer that for it 
aim, we need more studies in worldwide. The results of 
this study emphasizes on the CMV role in gastric cancer 
and of hit-and-run theory, which was described by the 
group Fred Rapp, and the role of cytomegalovirus onco-
modulatory support. 
Acknowledgements 
The authors of this project are grateful to Kerman 
pathology Laboratory in Afzalipour hospital staff and 
their cooperation in collecting samples, and so thanks for 
Kerman research center ethics committee of the Kerman 
University of Medical Sciences in approve this project. 
References
Abdirad A, Ghaderi-Sohi S, Shuyama K, et al (2007). Epstein-
Barr virus associated gastric carcinoma: a report from Iran 
in the last four decades. Diagn Pathol, 2, 1-9.
Alipov G, Nakayama T, Nakashima M, et al (2005). Epstein-Barr 
virus-associated gastric carcinoma in Kazakhstan. World J 
Gastroenterol, 11, 27-30.
Babacan NA, Egilmez HR, Yucel B, et al (2016). The prognostic 
value of UHRF-1 and p53 in gastric cancer. Saudi J 
Gastroenterol, 22, 25-9.
Babaei M, Pourfarzi F, Yazdanbod A, et al (2010). Gastric cancer 
in Ardabil, Iran--a review and update on cancer registry data. 
Asian Pac J Cancer Prev, 11, 595-9.
Bargiela-Iparraguirre J, Prado-Marchal L, Fernandez-Fuente 
M, et al (2016). CHK1 expression in Gastric Cancer is 
modulated by p53 and RB1/E2F1: implications in chemo/
radiotherapy response. Sci Rep, 6, 21519.
Brenner H, Rothenbacher D, Arndt V (2009). Epidemiology of 
stomach cancer. In ‘Cancer Epidemiology’, Eds Springer, 
467-77
Cainap SS, Fetica B, Buiga R, et al (2015). The prognostic role 
of EBER in pediatric cancer. Rom J Morphol Embryol, 56, 
1269-77.
Camargo MC, Kim KM, Matsuo K, et al (2015). Anti-
Helicobacter pylori Antibody Profiles in Epstein-Barr 
virus (EBV)-Positive and EBV-Negative Gastric Cancer. 
Helicobacter.
Camargo MC, Kim WH, Chiaravalli AM, et al (2014). Improved 
survival of gastric cancer with tumour Epstein-Barr virus 
positivity: an international pooled analysis. Gut, 63, 236-43.
Carrascal E, Koriyama C, Akiba S, et al (2003). Epstein-Barr 
virus-associated gastric carcinoma in Cali, Colombia. 
Oncology Reports, 10, 1059-62.
Chen XZ, Chen H, Castro FA, et al (2015). Epstein-Barr virus 
infection and gastric cancer: a systematic review. Medicine 
, 94, 792.
Chow PK, Ho JM, Ling AE, et al (1997). CMV colitis 
masquerading as colon cancer--an unusual presentation of 
acquired immunodeficiency syndrome. Singapore Med J, 
38, 32-4.
Corvalan A, Akiba S, Valenzuela MT, et al (2005). [Clinical and 
molecular features of cardial gastric cancer associated to 
Epstein Barr virus]. Rev Med Chil, 133, 753-60.
Faghihloo E, Saremi M, Mahabadi M, et al (2014a). Prevalence 
and Characteristics of Epstein-barr Virus-associated Gastric 
Cancer in Iran. Arch Iranian Med, 17, 767-70.
Faghihloo E, Saremi MR, Mahabadi M, et al (2014b). Prevalence 
and characteristics of Epstein-Barr virus-associated gastric 
cancer in Iran. Arch Iran Med, 17, 767-70.
Falasca F, Maida P, Gaeta A, et al (2014). Detection and 
quantification of EBV, HHV-6 and CMV DNA in the 
gastrointestinal tract of HIV-positive patients. Infection, 
42, 1033-7.
Fyock C, Gaitanis M, Gao J, et al (2014). Gastrointestinal CMV 
in an elderly, immunocompetent patient. R I Med J (2013), 
97, 53-6.
Grim SA, Pereira E, Guzman G, et al (2010). CMV PCR as a 
diagnostic tool for CMV gastrointestinal disease after solid 
organ transplantation. Transplantat, 90, 799-801.
He R, Mott BT, Rosenthal AS, et al (2011). An artemisinin-
derived dimer has highly potent anti-cytomegalovirus 
(CMV) and anti-cancer activities. PLoS One, 6, 24334.
Herrera-Goepfert R, Reyes E, Hernandez-Avila M, et al (1999). 
Epstein-Barr virus-associated gastric carcinoma in Mexico: 
analysis of 135 consecutive gastrectomies in two hospitals. 
Modern Pathol, 12, 873-8.
Zaruni Leila et al
Asian Pacific Journal of Cancer Prevention, Vol 17, 20162428
0
25.0
50.0
75.0
100.0
N
ew
ly
 d
ia
gn
os
ed
 w
ith
ou
t 
tr
ea
tm
en
t 
N
ew
ly
 d
ia
gn
os
ed
 w
ith
 t
re
at
m
en
t 
Pe
rs
is
te
nc
e 
or
 r
ec
ur
re
nc
e
Re
m
is
si
on
N
on
e
Ch
em
ot
he
ra
py
Ra
di
ot
he
ra
py
Co
nc
ur
re
nt
 c
he
m
or
ad
ia
tio
n
10.3
0
12.8
30.025.0
20.310.16.3
51.7
75.0
51.1
30.031.3
54.2
46.856.3
27.625.0
33.130.031.3
23.7
38.0
31.3
N
ew
ly
 d
ia
gn
os
ed
 w
ith
ou
t 
tr
ea
tm
en
t 
N
ew
ly
 d
ia
gn
os
ed
 w
ith
 t
re
at
m
en
t 
Pe
rs
is
te
nc
e 
or
 r
ec
ur
re
nc
e
Re
m
is
si
on
N
on
e
Ch
em
ot
he
ra
py
Ra
di
ot
he
ra
py
Co
nc
ur
re
nt
 c
he
m
or
ad
ia
tio
n
Jang EY, Park SY, Lee EJ, et al (2009). Diagnostic performance 
of the cytomegalovirus (CMV) antigenemia assay in patients 
with CMV gastrointestinal disease. Clin Infect Dis, 48, 
121-4.
Kanda T, Furuse Y, Oshitani H, et al (2016). Highly 
efficient CRISPR/Cas9-mediated cloning and functional 
characterization of gastric cancer-derived Epstein-Barr virus 
strains. J Virol.
Kavousi A, Bashiri Y, Mehrabi Y, et al (2014). Identifying high-
risk clusters of gastric cancer incidence in Iran, 2004 - 2009. 
Asian Pac J Cancer Prev, 15, 10335-7.
Lu B, Song XL, Song FL, et al (2010). [Construction, expression 
and location of eukaryotic expression vector CMV-FLAG-
RB in human prostate cancer PC-3 cells]. Nan Fang Yi Ke 
Da Xue Xue Bao, 30, 422-5.
Matsuura H, Kirschner AN, Longnecker R, et al (2010). Crystal 
structure of the Epstein-Barr virus (EBV) glycoprotein H/
glycoprotein L (gH/gL) complex. Proc Natl Acad Sci U S 
A, 107, 22641-6.
Mott BT, He R, Chen X, et al (2013). Artemisinin-derived dimer 
phosphate esters as potent anti-cytomegalovirus (anti-CMV) 
and anti-cancer agents: a structure-activity study. Bioorg 
Med Chem, 21, 3702-7.
Ngan RK, Lau WH, Yip TT, et al (2001). Remarkable 
application of serum EBV EBER-1 in monitoring response 
of nasopharyngeal cancer patients to salvage chemotherapy. 
Ann N Y Acad Sci, 945, 73-9.
Park JH, Kim EK, Kim YH, et al (2015). Epstein-Barr virus 
positivity, not mismatch repair-deficiency, is a favorable 
risk factor for lymph node metastasis in submucosa-invasive 
early gastric cancer. Gastric Cancer.
Parkin DM, Bray F, Ferlay J, et al (2005). Global cancer statistics, 
2002. CA Cancer J Clin, 55, 74-108.
Reza MA, Reza MH, Mahdiyeh L, et al (2015). Evaluation 
frequency of merkel cell polyoma, epstein-barr and mouse 
mammary tumor viruses in patients with breast cancer in 
Kerman, Southeast of Iran. Asian Pac J Cancer Prev, 16, 
7351-7.
Ryan JL, Jones RJ, Kenney SC, et al (2010). Epstein-Barr virus-
specific methylation of human genes in gastric cancer cells. 
Infect Agent Cancer, 5, 27.
Sadjadi A, Zahedi M, Nouraie M, et al (2007). The first 
population-based cancer survey in Kerman Province of Iran. 
Iranian J Public Health, 36, 26-34.
Sairenji T, Tajima M, Kanamori M, et al (2001). Characterization 
of EBV-infected epithelial cell lines from gastric cancer-
bearing tissues. Curr Top Microbiol Immunol, 258, 185-98.
Saridakis V, Sheng Y, Sarkari F, et al (2005). Structure of the 
p53 binding domain of HAUSP/USP7 bound to Epstein-
Barr nuclear antigen 1 implications for EBV-mediated 
immortalization. Mol Cell, 18, 25-36.
